LH601A,
ML334 compound,
LH601A,
CHEMBL2381968,
ML334,
1432500-66-7,
(1s,2r)-2-{[(1s)-1-[(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)methyl]-3,4-Dihydroisoquinolin-2(1h)-Yl]carbonyl}cyclohexanecarboxylic Acid,
4l7b,
MLS004683641,
SCHEMBL14933923,
CHEBI:125341,
BDBM50109398,
ML 334,
ZINC35851479,
AKOS027470233,
NCGC00386934-01,
SMR003455734,
BRD-K98948170-001-02-8,
BRD-K98948170-001-05-1,
BRD-K98948170-001-06-9,
BRD-K98948170-001-07-7,
BRD-K98948170-001-08-5,
BRD-K98948170-001-11-9,
(1S,2R)-2-((S)-1-((1,3-dioxoisoindolin-2-yl)methyl)-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)cyclohexanecarboxylic acid,
(1S,2R)-2-[[(1S)-1-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-3,4-dihydro-2(1H)-isoquinolinyl]carbonyl]cyclohexanecarboxylic acid,
(1S,2R)-2-[[(1S)-1-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-3,4-dihydro-2(1H)-isoquinolinyl]carbonyl]cyclohexanecarboxylicacid,
1VV,
LNENLABLFGGAFF-BHIFYINESA-N,